Connection

Justin Stebbing to Humans

Back to Details
This is a "connection" page, showing publications Justin Stebbing has written about Humans.
Justin Stebbing
Connection Strength
0.243
Humans
  1. Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial. Lancet Respir Med. 2021 12; 9(12):1349-1351.
    View in: PubMed
    Score: 0.008
  2. Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia. J Am Geriatr Soc. 2021 10; 69(10):2752-2758.
    View in: PubMed
    Score: 0.008
  3. Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals. Ann Rheum Dis. 2021 09; 80(9):1245-1246.
    View in: PubMed
    Score: 0.008
  4. The Emergence of Baricitinib: A Story of Tortoises Versus Hares. Clin Infect Dis. 2021 04 08; 72(7):1251-1252.
    View in: PubMed
    Score: 0.008
  5. JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Sci Adv. 2021 01; 7(1).
    View in: PubMed
    Score: 0.007
  6. Reducing transmission of SARS-CoV-2 with intranasal prophylaxis. EBioMedicine. 2021 Jan; 63:103170.
    View in: PubMed
    Score: 0.007
  7. SARS-CoV-2 (COVID-19) superspreader events. J Infect. 2021 01; 82(1):36-40.
    View in: PubMed
    Score: 0.007
  8. Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury. Cell Rep Med. 2020 11 17; 1(8):100145.
    View in: PubMed
    Score: 0.007
  9. COVID-19 and the risk to cancer patients in China. Int J Cancer. 2021 01 15; 148(2):265-266.
    View in: PubMed
    Score: 0.007
  10. Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19. J Allergy Clin Immunol. 2021 01; 147(1):107-111.
    View in: PubMed
    Score: 0.007
  11. Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients. EMBO Mol Med. 2020 08 07; 12(8):e12697.
    View in: PubMed
    Score: 0.007
  12. Lessons to Europe from China for cancer treatment during the COVID-19 pandemic. Br J Cancer. 2020 07; 123(1):7-8.
    View in: PubMed
    Score: 0.007
  13. Managing patients with cancer in the COVID-19 era. Eur J Cancer. 2020 06; 132:5-7.
    View in: PubMed
    Score: 0.007
  14. Baricitinib for COVID-19: a suitable treatment? - Authors' reply. Lancet Infect Dis. 2020 09; 20(9):1013-1014.
    View in: PubMed
    Score: 0.007
  15. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020 02 15; 395(10223):e30-e31.
    View in: PubMed
    Score: 0.007
  16. Decoding Metastatic Colorectal Cancer to Improve Clinical Decision Making. J Clin Oncol. 2019 08 01; 37(22):1847-1850.
    View in: PubMed
    Score: 0.007
  17. Harms of cigarette smoking: call to increase knowledge among children. Eur J Cancer Prev. 2019 01; 28(1):54-57.
    View in: PubMed
    Score: 0.006
  18. Total pathological complete response versus breast pathological complete response in clinical trials of reference and biosimilar trastuzumab in the neoadjuvant treatment of breast cancer. Expert Rev Anticancer Ther. 2018 06; 18(6):531-541.
    View in: PubMed
    Score: 0.006
  19. LMTK3 confers chemo-resistance in breast cancer. Oncogene. 2018 06; 37(23):3113-3130.
    View in: PubMed
    Score: 0.006
  20. Efficacy and safety of the trastuzumab biosimilar candidate CT-P6. Future Oncol. 2018 Aug; 14(19):1909-1919.
    View in: PubMed
    Score: 0.006
  21. Geographic Variation in EGFR Mutation Frequency in Lung Adenocarcinoma May Be Explained by Interethnic Genetic Variation. J Thorac Oncol. 2018 03; 13(3):454-458.
    View in: PubMed
    Score: 0.006
  22. Thirty years of Oncogene. Oncogene. 2018 02 01; 37(5):553-554.
    View in: PubMed
    Score: 0.006
  23. The importance of being earnest in post-publication review: scientific fraud and the scourges of anonymity and excuses. Oncogene. 2018 02 08; 37(6):695-696.
    View in: PubMed
    Score: 0.006
  24. Liquorice: a treatment for all sorts? Lancet Oncol. 2017 09; 18(9):1155.
    View in: PubMed
    Score: 0.006
  25. Chilli-too hot to handle? Lancet Oncol. 2017 08; 18(8):1005.
    View in: PubMed
    Score: 0.006
  26. CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial. Lancet Oncol. 2017 07; 18(7):917-928.
    View in: PubMed
    Score: 0.006
  27. Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR. Nucleic Acids Res. 2017 05 05; 45(8):4401-4412.
    View in: PubMed
    Score: 0.006
  28. Fasting: starving cancer. Lancet Oncol. 2017 04; 18(4):431.
    View in: PubMed
    Score: 0.006
  29. Circulating tumour cells as more than prognostic markers. Lancet Oncol. 2009 Dec; 10(12):1138-9.
    View in: PubMed
    Score: 0.003
  30. The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer. Br J Cancer. 2009 Apr 07; 100(7):1061-7.
    View in: PubMed
    Score: 0.003
  31. Prognostic significance of immune subset measurement in individuals with AIDS-associated Kaposi's sarcoma. J Clin Oncol. 2007 Jun 01; 25(16):2230-5.
    View in: PubMed
    Score: 0.003
  32. New drugs for old. J HIV Ther. 2005 Mar; 10(1):11-6.
    View in: PubMed
    Score: 0.002
  33. Circulating MicroRNAs in Small-bowel Neuroendocrine Tumors: A Potential Tool for Diagnosis and Assessment of Effectiveness of Surgical Resection. Ann Surg. 2021 07 01; 274(1):e1-e9.
    View in: PubMed
    Score: 0.002
  34. Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis. J Natl Cancer Inst. 2021 04 06; 113(4):371-380.
    View in: PubMed
    Score: 0.002
  35. Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID-A study. J Am Geriatr Soc. 2021 06; 69(6):1441-1447.
    View in: PubMed
    Score: 0.002
  36. Point-of-care SARS-CoV-2 serological assays for enhanced case finding in a UK inpatient population. Sci Rep. 2021 03 12; 11(1):5860.
    View in: PubMed
    Score: 0.002
  37. Reply to letter to the editor: baricitinib and toxicity is a rare occurrence. Expert Opin Drug Saf. 2020 10; 19(10):1371-1372.
    View in: PubMed
    Score: 0.002
  38. Asthma phenotypes, comorbidities, and disease activity in COVID-19: The need of risk stratification. Allergy. 2021 03; 76(3):955-956.
    View in: PubMed
    Score: 0.002
  39. A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib. Expert Opin Drug Saf. 2020 Nov; 19(11):1505-1511.
    View in: PubMed
    Score: 0.002
  40. Is asthma protective against COVID-19? Allergy. 2021 03; 76(3):866-868.
    View in: PubMed
    Score: 0.002
  41. Test, test, test for COVID-19 antibodies: the importance of sensitivity, specificity and predictive powers. Public Health. 2020 Aug; 185:88-90.
    View in: PubMed
    Score: 0.002
  42. CNS penetration of potential anti-COVID-19 drugs. J Neurol. 2020 Jul; 267(7):1880-1882.
    View in: PubMed
    Score: 0.002
  43. The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper. Crit Rev Oncol Hematol. 2019 Feb; 134:39-45.
    View in: PubMed
    Score: 0.002
  44. Human NK Cells Develop an Exhaustion Phenotype During Polar Degranulation at the Aspergillus fumigatus Hyphal Synapse. Front Immunol. 2018; 9:2344.
    View in: PubMed
    Score: 0.002
  45. Gene editing in the context of an increasingly complex genome. BMC Genomics. 2018 Aug 08; 19(1):595.
    View in: PubMed
    Score: 0.002
  46. Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. J Natl Cancer Inst. 2018 06 01; 110(6):560-567.
    View in: PubMed
    Score: 0.002
  47. TGF-ß induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression. Nat Commun. 2018 05 10; 9(1):1845.
    View in: PubMed
    Score: 0.002
  48. Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours. J Control Release. 2018 06 28; 280:87-98.
    View in: PubMed
    Score: 0.002
  49. Novel tumour suppressive protein encoded by circular RNA, circ-SHPRH, in glioblastomas. Oncogene. 2018 07; 37(30):4055-4057.
    View in: PubMed
    Score: 0.002
  50. Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors. PLoS One. 2018; 13(3):e0194790.
    View in: PubMed
    Score: 0.002
  51. Targeted cancer therapies: Oral health care implications. J Am Dent Assoc. 2018 Feb; 149(2):100-111.
    View in: PubMed
    Score: 0.002
  52. A randomised trial comparing the pharmacokinetics and safety of the biosimilar CT-P6 with reference trastuzumab. Cancer Chemother Pharmacol. 2018 03; 81(3):505-514.
    View in: PubMed
    Score: 0.002
  53. The Tumor-Suppressor Protein OPCML Potentiates Anti-EGFR- and Anti-HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer. Mol Cancer Ther. 2017 10; 16(10):2246-2256.
    View in: PubMed
    Score: 0.001
  54. The relationship between ethnicity, social deprivation and late presentation of colorectal cancer. Cancer Epidemiol. 2017 04; 47:88-93.
    View in: PubMed
    Score: 0.001
  55. Extracellular vesicles swarm the cancer microenvironment: from tumor-stroma communication to drug intervention. Oncogene. 2017 02 16; 36(7):877-884.
    View in: PubMed
    Score: 0.001
  56. Increased carcinoembryonic antigen (CEA) following neoadjuvant chemotherapy predicts poor prognosis in patients that undergo hepatectomy for liver-only colorectal metastases. Langenbecks Arch Surg. 2017 Jun; 402(4):599-605.
    View in: PubMed
    Score: 0.001
  57. Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2015 Jul; 152(2):231-7.
    View in: PubMed
    Score: 0.001
  58. Noncoding RNAs and the control of hormonal signaling via nuclear receptor regulation. J Mol Endocrinol. 2014 Oct; 53(2):R61-70.
    View in: PubMed
    Score: 0.001
  59. Cancer stem cells--therapeutic targeting or therapy? Lancet Oncol. 2013 Jun; 14(7):579-80.
    View in: PubMed
    Score: 0.001
  60. The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours. Br J Cancer. 2006 Nov 06; 95(9):1145-7.
    View in: PubMed
    Score: 0.001
  61. Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy. Clin Lymphoma. 2003 Sep; 4(2):86-92.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.